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ABSTRACT: 
Background: Attention deficit hyperactivity disorder (ADHD) is the most frequent behavioral 
disorder of childhood and is characterized by hyperactivity, attention problems and impulsivity. 
Pharmacological and behavioral therapies have been shown to be effective. In addition, the role 
of dietary compounds in the etiology and possibly the treatment of ADHD has attracted 
increasing attention. For example, the lack of dietary essential fatty acids has been suggested to 
be associated with symptoms of ADHD in humans. 
 
Objective: To investigate the effects of omega-3 polyunsaturated fatty acids (n-3 PUFAs) on 
locomotor activity in the spontaneously hypertensive rat (SHR) which has been proposed as an 
animal model of ADHD. 
 
Methods: Two groups of randomly assigned spontaneously hypertensive rats were fed with 
either n-3 PUFA-deficient or n-3 PUFA-enriched food (based on AIN93G) for six weeks and this 
was continued during the phase of behavioral testing. Locomotor activity was subsequently 
assessed using an open field test.  
 
Results: The results showed a marked difference in locomotor activity between the two groups 
of SHRs. In comparison with rats fed with n-3 deficient food, the animals on an n-3 enriched diet 
showed a statistically significant decrease in motor activity as assessed by the distance traveled.  
 
Conclusions: The present study demonstrates a marked reduction in locomotor activity 
following an n-3 PUFA-enriched diet in SHRs, i.e. the dietary enrichment with n-3 PUFAs 
reduced the motor activity in an established animal model of ADHD. Dietary n-3 PUFAs may 
therefore play a role in the pathophysiology of ADHD. 
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BACKGROUND: 
Attention deficit hyperactivity disorder (ADHD) is the most frequent behavioral disorder of 
childhood. The characteristic features of children and adolescents with ADHD are excessive 
motor activity, inattention and impulsiveness [1-4]. ADHD affects approximately 3-5 % of 
children and adolescents worldwide, with a higher prevalence in boys [5-7]. Genetic, 
neurobiological, social and environmental factors have been discussed in regard to the etiology 
of ADHD [5, 8, 9]. 
Nutrition is thought to play an important role in the behavior and cognitive functioning of 
children and dietary factors in the etiology of ADHD have been discussed [10, 11]. For example, 
it has been suggested that suboptimal omega-3 polyunsaturated fatty acid (n-3 PUFA) levels may 
contribute to ADHD symptoms. The rise in consumption of processed foods and vegetable oils 
has markedly increased the intake of omega-6 (n-6) PUFAs in Western diets, while the 
consumption of n-3 PUFAs in fish, nuts and seeds has declined. The ratio of n-3 : n-6 PUFAs has 
consequently decreased from about 1 in traditional diets to approximately 1:15 [12]. Some 
studies have reported that children with ADHD have reduced levels of blood n-3 PUFAs 
compared to matched healthy control subjects [13, 14] 
 
INTRODUCTION: 
Spontaneously hypertensive rats (SHRs) were developed by inbreeding rats of the Wistar-Kyoto 
(WKY) strain. The SHR is one of the best studied animal models of ADHD. In comparison to 
WKY rats, SHRs show several behavioral alterations characteristic of ADHD, including 
hyperactivity, impulsivity, poor sustained attention and an impaired ability to withhold responses 
[15-19]. In the present study, we have investigated the effects of an n-3 PUFA-enriched diet 
versus an n-3 PUFA-deficient diet on locomotor behavior in SHRs using an open-field paradigm.  
 
ANIMALS AND METHODS: 
Animals. In the present study, 20 7-week-old male SHRs were used (Charles River, Sulzbach, 
Germany). The rats were housed in groups of five animals per cage and kept on a 12:12 h light-
dark cycle (room temperature 22 ºC, humidity 50 %). They were given free access to water and 
the experimental diet, except for the behavioral testing period. At the beginning of the behavioral 
experiments water was provided ad libitum but food was restricted in order to prepare the 
animals for the experiments and to increase their motivation.  
The rats were at randomly assigned to two groups, i.e. group 1 (n-3 PUFA-enriched, n=10) 
received a diet enriched in n-3 PUFAs (Ssniff, Soest, Germany; based on AIN93G, for details 
see Table 1), while group 2 (n-3 PUFA-deficient, n=10) was fed with a diet deficient in n-3 
PUFAs (see Table 1). The experimental diets were provided for six weeks and during the 
subsequent phase of behavioral testing. 
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Table 1. Fatty acid composition of the experimental diets based on the AIN93G 
composition (source: Ssniff Spezialdiäten, Soest, Germany) 
_____________________________________________________________________ 
    n-3 PUFA-enriched diet n-3 PUFA-deficient dieT 
_____________________________________________________________________ 
Energy (Atwater), MJ/kg*  17.1    17.1 
kJ% protein    18    18 
kJ% carbohydrates   60    60 
kJ% fat     22    22 
 
Fatty acids, % of diet 
C 6:0     0.05    0.05 
C 8:0     0.59    0.62 
C 10:0     0.47    0.49 
C 12:0     3.48    3.64 
C 14:0     1.35    1.41 
C 16:0     0.84    0.85 
C 18:0     0.29    0.28 
C 20:0     0.01    0.01 
C 18:1     0.82    0.77 
C 18:2 n6    1.54    1.58 
C 18:3 n3    0.27    0.01 
____________________________________________________________________ 
* Physiological fuel value 
 
Apparatus: The rats’ locomotor activity was measured in an open field. The open field used 
consisted of a rectangular arena (size: 82.5 x 82.5 cm with walls 40 cm high), made of dark gray 
synthetic material. The locomotor activity was recorded by a fixed digital video system. This 
data was digitized and analyzed using the video tracking system ETHOVISION 3.0 (Noldus, 
Wageningen, The Netherlands). The distance traveled in the open field over 15 minutes was 
recorded.  
 
Procedure: Rats were tested once daily for six consecutive days. Each rat was individually 
placed in the center of the open field and allowed to explore freely for 15 minutes. Prior to each 
trial all open-field surfaces were cleaned with 70 % alcohol in order to remove odors and/or 
residues of rats tested previously. The rats were tested each day in random order. The animals’ 
body weight was measured daily in order to ensure normal weight gain and to prevent a weight 
loss of more than 10 %. At the time of behavioral testing, there were no significant differences in 
body weight between the two experimental groups.  
 
Statistics: The statistical analysis of differences between the two groups (n-3 PUFA-enriched 
and n-3 PUFA-deficient) was performed with Mann-Whitney U-test using the Statistical Package 
for Social Sciences 17.0 (SPSS) for Windows. An alpha level of .05 was applied. 
 centre 
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Ethics: This study was performed in accordance with national laws (German Law on Protection 
of Animals) and European laws, and the principles of laboratory animal care (NIH publication 
No. 86-23, revised 1985).  
 
RESULTS: 
The locomotor activity on six consecutive days (i.e. the distance travelled within 15 minutes) of 
SHRs following consumption of n-3 deficient or n-3 enriched diet for six weeks (plus six days of 
testing) is given in Table 2. The distance travelled of the n-3 deficient SHR group was 
significantly increased on days 2, 4, 5, 6 and over the total of 6 days when compared to the 
animals fed with the n-3 enriched diet. 
 
Table 2. Distance travelled in the open field of the n-3 PUFA-deficient and n-3 PUFA-enriched 
SHR groups (means  ± standard errors)  
_________________________________________________________________________ 
   n-3 PUFA-deficient n-3 PUFA-enriched p-value z-value 
_________________________________________________________________________ 
Day 1   5858.6 ± 156.6 5526.0 ± 191.2 0.226  -1.21 
Day 2    6114.8 ± 242.5 * 4997.1 ± 257.6 0.013  -2.50 
Day 3   5014.1 ± 181.2 5108.5 ± 251.4 1  0 
Day 4   5664.2 ± 158.7 * 4843.0 ± 162.9 0.003  -2.95 
Day 5    5333.9 ± 320.3 * 4381.6 ± 151.0 0.023  -2.27 
Day 6   5549.4 ± 317.2 * 4578.7 ± 205.0 0.041  -2.04 
 
Days 1-6 (mean) 5589.2 ± 165.5 * 4905.80 ± 130.2 0.007  -2.72 
_________________________________________________________________________ 
* p < .05 compared to n-3 PUFA-enriched group 
 
DISCUSSION: 
Long-chain PUFAs are essential for the central nervous system, e.g. the most predominant n-3 
PUFA in the brain, docosahexaenoic acid (DHA) [20, 21], increases cellular membrane 
flexibility and is involved in the regulation of neurotransmission, myelination, and other cellular 
activities. An impoverished n-3 PUFA diet in rodents over several generations has been shown to 
result in a 50 to 80 % deficit in brain DHA phospholipids and in cognitive deficits including the 
performance in spatial learning and other learning tasks [22-24]. 
Dietary factors including the dietary lack of n-3 PUFAs have been discussed in regard to 
dyfunctions found in ADHD [for review of animal research see 25]. Several clinical trials with 
mixed results have been conducted to investigate whether some behavioral or cognitive 
symptoms of children with ADHD can be improved by long-chain PUFA supplementation [26]. 
Locomotor hyperactivity is the most easily discerned symptom of ADHD. The present study 
investigated the effects of a diet rich or impoverished in n-3 PUFAs on locomotor activity in rats 
using an open-field paradigm. We have used SHRs which have been proposed as an animal 
model of ADHD [e.g. 19]. 
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The present results showed a marked difference in locomotor activity between the two 
groups of SHRs. In comparison with rats fed with n-3 PUFA-deficient food, the animals on an n-
3 PUFA-enriched diet showed a statistically significant decrease in motor activity as assessed by 
the distance traveled in the open field. 
Previous studies investigating the role of dietary PUFAs on locomotion in rodents reported 
inconsistent findings. A study in mice investigating the effects of a diet deficient in α-linolenic 
acid followed or not by supplementation with phospholipids rich in n-3 PUFAs found no 
significant effect between diet groups on open-field motor activity [27]. A fish oil enriched diet 
was reported to reduce ambulatory activity in Wistar rats [28].  In SHRs, dams were given n-3 
PUFA-enriched feed during pregnancy and their offspring continued on this diet [29]. This study 
showed an n-3 PUFA-induced reduction in spontaneous locomotion.  
Given the hypothesis that SHR is a valid animal model of ADHD symptoms including 
hyperactivity [for critical review see 30], one could conclude from our data that the diet enriched 
with n-3 PUFAs reduced the rats’ hyperactivity. However, the present results were obtained by 
comparison with animals fed with n-3 PUFA-deficient food. Further studies are therefore needed 
in order to establish if the (hyper) activity of SHRs can also be ameliorated when the animals are 
fed with a balanced diet. In addition, it remains of interest whether other ADHD core symptoms 
such as inattention or impulsivity are affected by dietary n-3 PUFAs.   
 
CONCLUSIONS: 
The present study demonstrated a marked reduction in locomotor activity following an n-3 
PUFA-enriched diet in SHRs, i.e. the dietary enrichment with n-3 PUFAs reduced the activity in 
an established animal model of ADHD when compared with an n-3 PUFA-deficient diet. Dietary 
n-3 PUFAs appear to affect locomotor activity in rats and may play a role in the pathophysiology 
of ADHD. 
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